MTOR and colorectal carcinoma: Increased expression of miR-4999-5p has been demonstrated in CRC, which can also modulate the glucose metabolic reprogramming of CRC cells by targeting the critical molecule of mTOR signaling pathway, namely, AMP-Activated Protein Kinase (PRKAA2) (19).